1,698
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group

, , , , &
Pages 146-152 | Received 29 Apr 2016, Accepted 23 Aug 2016, Published online: 01 Nov 2016

References

  • Pivtoraiko VN, Abrahamson EE, Leurgans SE, et al. Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease. Neurobiol Aging 2015;36:12–19.
  • Anand R, Gill KD, Mahdi AA. Therapeutics of Alzheimer’s disease: past, present and future. Neuropharmacology 2014;76:27–50.
  • García-Alberca JM. Cognitive intervention therapy as treatment for behavior disorders in Alzheimer disease: evidence on efficacy and neurobiological correlations. Neurología (English Edition) 2015;30:8–15.
  • Small G, Bullock R. Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease. Alzheimers Dement 2011;7:177–84.
  • Molinuevo JL, Gauthier S. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer’s disease. Alzheimers Dement 2013;9:326–31.
  • Mukherjee PK, Kumar V, Mal M, et al. Acetylcholinesterase inhibitors from plants. Phytomedicine 2007;14:289–300.
  • Li RS, Wang XB, Hu XJ, et al. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer’s disease. Bioorg Med Chem Lett 2013;23:2636–41.
  • Asadipour A, Alipour M, Jafari M, et al. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. Eur J Med Chem 2013;70:623–30.
  • Silva T, Reis J, Teixeira J, et al. Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes. Ageing Res Rev 2014;15:116–45.
  • Liu HR, Huang XQ, Lou DH, et al. Synthesis and acetylcholinesterase inhibitory activity of Mannich base derivatives flavokawain B. Bioorg Med Chem Lett 2014;24:4749–53.
  • Liu HR, Liu XJ, Fan HQ, et al. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors. Bioorg Med Chem 2014;22:6124–33.
  • Liu HR, Fan HQ, Gao XH, et al. Design, synthesis and preliminary structure–activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives. J Enzyme Inhib Med Chem 2016;3:580–9.
  • Oztaşkın N, Cetinkaya Y, Taslimi P, et al. Antioxidant and acetylcholinesterase inhibition properties of novel bromophenol derivatives. Bioorg Chem 2015;60:49–57.
  • Aksu K, Topal F, Gulcin İ, et al. Acetylcholinesterase inhibitory and antioxidant activities of novel symmetric sulfamides derived from phenethylamines. Arch Pharm 2015;348:446–55.
  • Burmaoglu S, Algul O, Anil DA, et al. Synthesis and anti-proliferative activity of fluoro-substituted chalcones. Bioorg Med Chem Lett 2016;26:3172–6.
  • Cole AL, Hossain S, Cole AM, et al. Synthesis and bioevaluation of substituted chalcones, coumaranones and other flavonoids as anti-HIV agents. Bioorg Med Chem 2016;24:2768–76.
  • Syam S, Abdelwahab SI, Al-Mamary MA, et al. Synthesis of chalcones with anticancer activities. Molecules 2012;17:6179–95.
  • Chimenti F, Fioravanti R, Bolasco A, et al. Chalcones: a valid scaffold for monoamine oxidases inhibitors. J Med Chem 2009;52:2818–24.
  • Lee YH, Shin MC, Yun YD, et al. Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors. Bioorg Med Chem 2015;23:231–40.
  • Edward J, Cragoe J, Rahway NJ. 1-(Substituted-aminoalkoxyphenyl)-2-methylene-1-alkanones, compositions and their use. US 4342782[P] Aug 3, 1982.
  • Goldbeg WM, Montclair U, Rachlin AI, et al. Basic ketones and salts thereof. US 2668813[P] Feb 9, 1954.
  • Mokale SN, Dube PN, Bhavale SA, et al. Synthesis, in-vitro screening, and docking analysis of novel pyrrolidine and piperidine-substituted ethoxy chalcone as anticancer agents. Med Chem Res 2014;24:1842–56.
  • Insuasty B, Montoya A, Becerra D, et al. Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl)amino]chalcones and hydrazine as potential antitumor and antimalarial agents. Eur J Med Chem 2013;67:252–62.
  • Yu H, Li WM, Kan KKW, et al. The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine. J Pharmaceut Biomed Anal 2008;46:75–81.
  • Ellman GL, Courtney KD, Andres VJ, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
  • Skrzypek A, Matysiak J, Niewiadomy A, et al. Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors. Eur J Med Chem 2013;62:311–19.
  • Liu HR, Zhou C, Fan HQ, et al. Novel potent and selective acetylcholinesterase inhibitors as potential drugs for the treatment of Alzheimer's disease: synthesis, pharmacological evaluation, and molecular modeling of amino-alkyl-substituted fluoro-chalcones derivatives. Chem Biol Drug Des 2015;86:517–22.
  • Glave WR, Hansch CJ. Relationship between lipophilic character and anesthetic activity. J Pharm SCI-US 1972;61:589–91.